Exploring Common CDISC ADaM Conformance Findings Blog Post
Trevor Mankus Product Manager March 27, 2025 Intro to CDISC ADaM Conformance ADaM data are required by the FDA and PMDA and accepted by China’s NMPA. Agencies often begin reviews...BaseCase Demo Page
BaseCase See BaseCase in action! Discover how BaseCase can transform your value communication. Request a personalized demo and experience the impact firsthand! Specifically designed to empower market access teams in...
Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development Blog Post
You may also like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Behind the Science: Meet Sr. Director Craig Comisar Blog Post
You may also like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Behind the Science: Meet Project Manager Holly Dierkers Blog Post
You may also like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Introducing the new Certara.com: Transforming drug development for good, together. Blog Post
Sheila Rocchio March 26, 2025 We’re thrilled to introduce the launch of our revamped website and refreshed brand—welcome to the new Certara.com! This is more than a simple visual update;...
QSP Modeling Optimizes FIH Dose Selection for Multiple Myeloma Therapy Blog Post
Multiple myeloma, the second most common blood cancer, affects an estimated 160,000 individuals annually worldwide (Ludwig et al. 2020). Despite advancements in therapies like monoclonal antibodies and T-cell engages (TCEs),...
Quantitative systems pharmacology model of mRNA lipid nanoparticle for two programs at the preclinical to clinical transition Blog Post
This case study features Applied BioMath's* collaboration with Alexion Pharmaceuticals. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, focused on developing therapies for rare diseases. Crigler-Najjar syndrome type 1 (CN1) is...
